SlideShare a Scribd company logo
CHARACTERIZATIONS OF HORSE SERUM CHOLINESTERASE FOR MOLECULAR
WEIGHT AND ANALYSIS UNDER ENVIRONMENTAL CONDITIONS
Lukas Isenhart, Sage Jordan, Leo Pezzementi
Biology Department
Birmingham-Southern College
Birmingham, Alabama
2 May, 2014
2
Abstract:
After analysis of horse blood serum cholinesterase for substrate specificity, kinetic parameters,
substrate inhibition, molecular weight, and effects of temperature, pH, and [NaCl], we
determined the enzyme inherent in horse serum to be butyrylcholinesterase (BChE). The enzyme
experienced inhibition by substrates too large to bind to an actyl gorge of acetylcholinesterase
(AChE) and displayed responses to pH, temperature, and [NaCl] – these results confirm the data
of previous studies that also suggested the existence of BChE in horse serum.
1. Introduction
Acetylcholine, a neurotransmitter in humans and many other organisms, functions as an
excitatory signal for the contraction of skeletal muscle fibers. If not for cholinesterases (ChEs) –
which are a family of enzymes known to catalyze the hydrolysis of acetylcholine into choline
and acetic acid, thereby impeding the neurotransmitter’s ability to signal contraction – skeletal
muscles would be incapable of relaxation (Pohanka, 2011). Despite their differences in substrate
specificity and susceptibility to inhibitors, butyrylcholinesterase (BChE) and acetylcholinesterase
(AChE) both qualify as cholinesterases (Radic and Taylor, 2006; Monteiro et al., 2005). AChE is
easily observed in the central nervous system and in neuromuscular junctions, functioning as the
primary enzyme involved in the hydrolysis of acetylcholine, but BChE isn’t understood so well.
Though more commonly found in the liver and serum of organisms (Radic and Taylor, 2006),
people completely deficient in BChE can lead generally healthy, disease-free lives (Manoharan
et al., 2007). BChE is known to improve the hydrolysis rates of cocaine (Lynch et al., 1997),
protect mice from cocaine’s toxic effects (Morasco and Goldfrank, 1996), and protect the human
body from organophosphorous AChE inhibitors, suggesting a detoxification role in the body
(Saxena et al., 2006).
AChE is structurally determined to have much narrower substrate specificity than BChE,
as they bind specifically to ACh. BChE has a wider active site than Torpedo californica AChE,
3
with the AChE having a catalytic gorge – lined mostly with aromatic residues – that reaches
halfway into the protein (Sussman et al., 1991). The existence of large aromatic residues from
the volume of the AChE aromatic gorge creates a long and narrow path for substrates, allowing
for higher selectivity of the enzyme at its active site (Sussman et al., 1991). Substrates that bind
to the choline binding site at the base of the AChE are smaller and more positively charged due
to the charge of the many different negatively-charged aromatic residues. The enzyme would
require more positively charged substrates or inhibitors than BChE. BChE’s active site is wider,
it has fewer aromatic residues lining the catalytic gorge and therefore is more voluminous and
more easily accommodating for various substrates, specifically for butyrylcholine (Nicolet et al.,
2003). This difference in substrate specificities can prove to be a valuable tool in the
identification of enzymes within sera. The larger and wider size of BChE’s catalytic gorge also
allows for easier binding of inhibitors that may bind in the gorge and at an active site by the acyl
pocket, there isn’t any substrate inhibition at peripheral site due to BChE’s possession of an
alanine instead of a tryptophan.
Vertebrate sera each display different levels of certain cholinesterases. The dominant
cholinesterase present in plasma of Portugese bird species Morus bassanus, Ciconia ciconia, and
Ardea cinerea is BChE (Santos et al., 2012). The plasma of other bird species, including
Neophron percnopterus, Cincloramphus cruralis, Anthus novaeseelandiae, and Accipiter nisus,
also displayed a dominance of BChE (Strum et al., 2008; Fildes et al., 2009). BChE, as it appears
in human blood serum, has an estimated molecular weight of 366,000 after ultracentrifugation
and gel electrophoresis (Dasan and Liddell, 1969). It is reported that BChE also appears in horse
serum and can be commercially purified, resulting in a molecular weight of 317,000 ± 12,000 in
a diluted phosphate (Lee and Harpst, 1971).
4
With regard to inhibition of cholinesterases, human AChE displays more inhibition
resulting from pyrilium and selenopyrilium salts than does horse BChE while horse BChe is
more easily inhibited by thiopyrilium salts than human AChE, suggesting a method for
identification of the type of enzyme in horse serum by analyzing response to salts (Brestkin et
al., 1988). In rat brain capillaries, BChE displayed longer functionality at higher temperatures
and a higher activation energy at normal body temperatures than did AChE (Hernandez and
Catalan, 1986). Additionally, cholinesterase enzyme activity increased at pH values ranging from
5 to 10 before denaturing at pH of 11 (Eränkö, 1972). Based on the dominant appearance of
BChE in horse serum as suggested by Lee and Harpst (1971), we hypothesize that BChE will
again be the dominant cholinesterase in horse serum after filtration and analysis for molecular
weight. This study will determine the type of cholinesterase inherent in horse serum as well as
address its molecular characteristics and interactions with substrates and environment factors.
2. Materials and Methods
2.1. Preparation for and Execution of Electrophoresis
A sample containing purified cholinesterase was added directly to sample buffer (0.5 M Tris-
HCL, pH 6.8, 10% glycerol, 0.2% SDS, 0.25%bromophenol blue) at the same volume. This
solution and a solution containing molecular weight standards (proteins with standard weights of
250, 150, 100, 75, 50, 37, 25, 20, 15, and 10 kD) were heated for 4 minutes at 95ºC. Samples of
15µg for molecular weight standards and 7.5 and 12.5µg of purified cholinesterase (mixed with
sample buffer) were loaded into an electrophoresis chamber above 4-20% polyacrylamide gel.
The samples were electrophoresed in running buffer (0.25 M Tris, 0.2M glycine and 0.1% SDS)
at 200 V for 30 minutes.
5
2.2. Staining SDS-polyacrylamide Gel
After electrophoresis the gel was removed from the gel cassette, incubated in dH2O for 5
minutes, then gently shaken for 1 hour in Bio-Safe Coomassie staining solution. The gel was
then incubated in dH2O overnight.
2.3. Measurement of Sample Migrations
The gel was removed from the dH2O and placed on a light box. Measurements of migration
distances were recorded in mm from the base of each well to the leading edge of each band in all
molecular weight and cholinesterase samples.
2.4. Plotting Data
Using Sigma Plot, log values of standard molecular weights were plotted in relation to distance
(mm). To determine the molecular weight of horse serum cholinesterase the equation
Y=M(X)+B was used and Y was solved for using values of slope, distance migrated, and y-
intercept. We then determined the anti-log of Y to find the molecular weight of horse serum
cholinesterase.
2.5. Effects of Environmental Temperature
Enzyme samples and blanks containing identical pH values and [NaCl] concentrations were
heated for ten minutes at individual temperatures ranging between 4º and 90ºC, where 4ºC acted
as the control temperature and other higher temperatures were experimental values. After
heating, each sample was chilled in an ice bath to preserve the enzyme’s resulting shape.
Spectrophotometric analyses were staggered in five minute intervals; each analysis involved
spectrophotometry for 2 minutes while allowing time for other preparatory processes. After each
2 minute sample-analysis at ice bath temperature, a sample’s resulting slope was converted into
6
percent control activity. Staggered time intervals continued until every blank and sample
experienced analysis by the spectrophotometer. Data were then plotted using Sigma Plot.
2.6. Effects of Environmental pH
Enzyme samples existed in Ellman’s solutions with a pH range of 4.5-8.5,where the pH value of
7 acted as a control. The spectrophotometer was blanked before each measurement, where an
experimental pH value would receive an enzyme and incubate at room temperature for
approximately 10 minutes before receiving a dose of substrate with buffer before
spectrophotometric analysis for two minutes. Experimental analyses were staggered every 5
minutes, resulting slopes were converted to percent control activity, then the converted data was
organized using Sigma Plot software. Complacency
2.7. Effects of Environmental [NaCl]
This procedure is similar to the analysis of pH’s effects on enzyme activity. Aside from replacing
pH addition with the addition of [NaCl] molarities ranging from 0 to 2.5 M, where 0M acted as a
control, the procedure for spectrophotometric analysis of [NaCl] and its effects on horse serum
cholinesterase is virtually identical to that of environmental pH.
7
3. Results
Figure 1. Substrate specificities of horse serum cholinesterases. Data inidicate initial velocities of
ATCh’s and BTCh’s after Ellman esterase assay of serial dilutions. Acetylthiocholine
specificities represented by (●), butyrlthiocholine represented by (○).
Horse serum cholinesterases exhibited higher velocities of cholinesterase activity at higher
substrate concentrations. BTCh exhibited more substrate activity than ATCh, but activity level
out at approximately 1.0mM (Fig. 1.).
Table 1. Kinetic parameters for hydrolysis of ATCh and BTCh by horse serum cholinesterase.
Substrate concentration (Km) calculated at 0.5 maximum velocity; maximum velocity (Vmax) was
also calculated. Standard error suggests N=14.
Substrate Km (mM ± SE) Vmax (µm/mM ± SE)
ATCh 0.34 ± 0.08 43.29 ± 4.24
BTCh 0.28 ± 0.06 59.16 ± 3.20
Lower concentrations of BTCh still managed to produce higher maximum velocities during
hydrolysis than did ATCh, though SE values do suggest overlapping standard errors for
concentrations (Table 1.). Maximum velocity values differed even when including standard error
values, suggesting that BTCh has a higher maximum velocity than ATCh (Table 1.).
8
Inhibitor Concentration (M)
10-11 10-10 10-9 10-8 10-7 10-6 10-5 10-4 10-3 10-2
PercentControlChE
0
20
40
60
80
100
120
140
Figure 2. Percent activity of horse serum cholinesterase as a function of inhibitor concentrations.
This depicts data resulting from the addition of inhibitors Iso-OMPA (○), BW284C51 (▼), and
Eserine (●) into Ellman esterase assay. The results analyzed as percent activity in regard to
inhibitor concentration (M). N=4 for Eserine and BW284C51while N=5 for Iso-OMPA.
Ic50 values for inhibitors include 1.7294E-007 (Eserine), 2.5548E-006 (Iso-OMPA), and
3.8881E-005 (BW284c51) (Fig. 2.). As inhibitor concentrations increased, percent control ChE
decreased; Eserine percent control ChE decreased sooner than other inhibitors while BW284C51
decreased at slowest rate (Fig. 2.).
9
Table 2. Inhibitor dimensions of molecular modeling by SPARTAN software.
Inhibitor Length ± SE Width ± SE
BW284c51 20.92 ± 0.53 5.24 ± 0.29
Decamethonium 18.37 ± 0.33 3.94 ± 0.28
Ethopropazine 9.69 ± 0.28 8.72 ± 0.35
Iso-OMPA 9.58 ± 0.35 8.09 ± 0.53
Decamthionium and BW284c51 exhibited molecular shapes that were longer and thinner than
the molecular shapes of Ethopropazine and Iso-OMPA, which were shorter and wider (Table 2.).
Distance Migrated (mm)
10 20 30 40 50 60 70
MolecuarWeight
103
104
105
106
Figure 3. Distance migrated (mm) after electrophoresis for 30 minutes at 200V by samples (µg)
of molecular weight standards and purified cholinesterase. Lane 1 of electrophoresis gel
represents molecular weight standard to specified masses (kD), lane 2 contains 12.5µg purified
cholinesterase while Lane 3 contains 7.5µg purified cholinesterase.
Standard molecular weights displayed an inverse relationship with distance migrated – larger
molecular weights (the bands in the gel) travelled shorter distances than smaller molecular
weights (Fig. 1). The molecular weight of horse serum cholinesterase was determined to be
66456 + 2839; N=10 (Fig. 1.).
Lanes
1 2 3
10kD
15kD
20kD
25kD
37kD
50kD
75kD
100kD
150kD
250kD
10
11
Figure 4. Varying Effects of Environmental Factors on Horse Serum Cholinesterase. Graph A
displays effects of pH in a sigmoidal fashion, where percent control activity increased until an
approximate pH value of 8; data normalized to pH of 7. Graph B displays effects of Temperature
as measured in degrees Celsius, lacking dramatic changes resulting from temperature until a
50°C where the enzyme percent activity declines and flatlines at 0; data normalized to 100°C
Graph C displays the negative correlation between increasing molarity of [NaCl] and percent
control ChE activity; data normalized to 0 M. Data are the mean of standard error and 9
determinations.
Horse Serum Cholinesterase activity experienced positive responses to less acidic
environments, with pH values displaying a sigmoidal relationship (Fig. 1.). Activity as a function
of pH, lower values led to less control cholinesterase activity whereas higher function of pH
values led to the higher percent control cholinesterase activity (Fig. 1A). Standard SE values
overlap between data points 8 and 9, suggesting the insignificance of apparent reduction in
percent control cholinesterase activity (Fig. 1.). Cholinesterase activity in horse serum also
experienced a sharp decline in functional ability after relatively constant responses to
environmental temperature, but when temperature values rose above 40°C percent control
cholinesterase activity dipped and flat-lined at 0% around 70°C (Fig. 1.). Horse serum
12
cholinesterases additionally experienced a negative relationship with rising molarities of [NaCl],
with the highest molarity of 2.5 displaying the least percent control cholinesterase activity (Fig.
1.).
4. Discussion
Horse serum cholinesterases displayed a highly-accomodating substrate specificity for
larger, wider substrates like Ethopropazine and Iso-OMPA, suggesting that the enzyme in horse
serum possessed an adequately-sized catalytic gorge to allow the entrance of such inhibitors (Fig.
2.). Enzyme activity increased as butyrylthiocholine concentrations increased, also suggesting
that the enzyme had increased binding capabilities with substrates of varying lengths and widths,
a common characteristic of BTChE and an idea common with previous research (Sussman et al.,
1991) (Fig. 1.).
Molecular modeling represents BW284c51and Decamethonium as inhibitors exhibiting
substrate specifity for long and thin catalytic gorges of enzymes while Ethopropazineand and
Iso-OMPA exhibit larger and wider enzyme specificities (Table 2.). It appears that BChE is the
dominant enzyme available in horse serum because the enzyme is accepting of both ACh and
BCh while also displaying more inhibition to varying sizes and shapes of inhibitors. The
existence of 14 large aromatic residues in the aromatic gorge of AChE explains its high
specificity, as the aromatic residues fill the gorge and leave little remaining space for the
entrance of substrates (Sussman et al., 1991). Because of this narrower gorge in AChE , it would
be expected that BCh – a larger, wider molecule – would produce slower kinetic interactions
with that particular enzyme because the substrate simply wouldn’t fit inside the catalytic gorge
(Table 2). But within this experiment the enzyme displayed an increased kinetic relationship with
BCh and ACh, which again suggests the existence of BChE as the enzyme inherent in horse
13
serum due to its more accommodating substrate specificity resulting from ist possession of only
8 aromatic amino acids (Table. 1.). This accomodation also helps explain BChE’s effectiveness
as a detoxifying agent in mice and humans (Morasco and Goldfrank, 1996; Saxena et al., 2006;
Lynch et al., 1997).
Environmental factors affected horse serum cholinesterase in various manners, with
enzymes functioning best at a pH of 8, a temperature of 0 to 40°C, and at low (0 – 0.5M)
concentrations of [NaCl] (Fig. 4.). These data indicate optimum conditions for the horse serum
cholinesterase, further identify the enzyme to be BChE (Brestkin et al., 1988; Hernandez and
Catalan, 1986; Eränkö, 1972). Though data for molecular weight differed from previous
literature – likely a result oft he differences between monomer and tetramer analyses – data in
this study pertaining to environmental factors, substrate specificities, and enzyme kinetics
correspond with a previous studies’ assertions that the enzyme inherent in horse serum is BChE
(Lee and Harpst, 1971; Sussman et al., 1991). The molecular weight of horse serum
cholinesterase in this experiment was deterimined to be (66456 + 2839; N=10) (Fig. 1.).
However, there are multiple issues with this study. All treatments to determine
environmenatal variability and protein function required staggered measurement periods by
spectrophotometry, inconsistent machine-blanking and transfer times between the addition of
substrates and actual measurement of cuvettes in the spectrophotomer likely led to discrepencies
in data. Data measurements were rushed, future studies should eliminate the propensity for
measurement mistakes by individually analyzing test solutions.
5. Acknowledgements
We would like to thank Birmingham-Southern College both for generously supplying materials
and for allowing the use of facilities.
14
Literature Cited
Brestkin, A.P., E.N. Dmitrieva, I.G. Zhukovskiĭ, A.A. Safonova and V.A. Sedavkina (1988)
Reversible inhibition of cholinesterases by salts of pyrilium, thiopyrilium and
selenopyrilium derivatives. Ukr. Biokhim. Zh. 60, 35-40.
Dasan, P.K. and J.D. Liddell (1969) Purification and Properties of Human Serum Cholinesterase.
Biochem. J. 116, 875-881.
Eränkö, L. (1972) Effect of pH on the activity of nervous cholinesterases of the rat towards
different biochemical and histochemical substrates and inhibitors. Histochemie 33, 1-14.
Fildes, K., J.K. Szabo, M.J. Hooper, W.A. Buttemer and L.B. Astheimer (2009) Plasma
cholinesterase characteristics in native Australian birds: significance for monitoring avian
species for pesticide exposure. EMU 109, 41–47.
Hernandez, F. and R.E. Catalan (1986) Temperature effects on cholinesterases from rat brain
capillaries. Biosci. Rep. 6, 573-577.
Lee, J.C. and J.A. Harpst (1971) Purification and properties of butyrylcholinesterase from horse
serum. Arch. Biochem. Biophys.145, 55-63.
Lynch, T.J., C.E. Mattes, A. Singh, R.M. Bradley, R.O. Brady and K.L. Dretchen
(1997) Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol. Appl.
Pharmacol. 145, 363–371.
Manoharan, I., R. Boopathy, S. Darvesh and O. Lockridge (2007) A medial health report on
individuals with silent butyrylcholinesterase in Vysya community of India. Clin. Chim.
Acta. 378, 128-35.
Monteiro, M., C. Quintaneiro, F. Morgado, A. Soares and L. Guilhermino (2005)
Characterization of the cholinesterases present in head tissues of the estuarine fish
Pomatoschistus microps: Application to biomonitoring. Ecotoxicol. Environ. Saf. 62,
341–347.
Morasco, R.S. and L.R. Goldfrank (1996) Administration of purified human plasma
cholinesterase protects against cocaine toxicity in mice. J. Toxicol. Clin.
Toxicol. 34, 259–266.
Nicolet, Y., O. Lockridge, P. Masson, J.C. Fontecilla-Camps and F. Nachon (2003) Crystal
structure of human butyrylcholinesterase and of its complexes with substrate and
products. J. Biol. Chem. 278, 41141-41147.
Pohanka, M. (2011) Cholinesterases, a target of pharmacology and toxicology. Biomed. Pap.
Med. Fac. Univ. Palacky Olomouc Czech Repub. 155, 219-229.
15
Radic, Z. and P. Taylor (2006) Toxicology of Organophosphate and Carbamate Pesticides.
Elsevier Academic Press. 1, 161–186.
Santos, C., M.S. Monteiro, A.M. Soares and S. Loureiro (2012) Characterization of
Cholinesterases in Plasma of Three Portuguese Native Bird Species: Application to
Biomonitoring. PLoS ONE 7, 1-8.
Saxena, A., W. Sun, C. Luo, T.M. Myers, I. Koplovitz, D.E. Lenz, and B.P. Doctor (2006)
Bioscavenger for protection from toxicity of organophosphorus compounds. J. Mol.
Neurosci. 30, 145-148.
Strum, K.M., M. Alfaro, B. Haase, M.J. Hooper, K.A. Johnson, R.B. Lanctot, A.J. Lesterhuis, L.
López, A.C. Matz, C. Morales, B. Paulson, B.K. Sandercock, J. Torres-Dowdall and M.E.
Zaccagnini (2008) Plasma cholinesterases for monitoring pesticide exposure in nearctic-
neotropical migratory shorebirds. Ornitologia Neotropical 19, 641-651.
Sussman, J. L., M. Harel, F. Frolow, C. Oefner, A. Goldman, L. Toker and I. Silman (1991)
Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic
acetylcholine-binding protein. Science 253, 872–879.

More Related Content

What's hot

Effects of eugenol on resting tension of rat atria
Effects of eugenol on resting tension of rat atriaEffects of eugenol on resting tension of rat atria
Effects of eugenol on resting tension of rat atria
Robson Olivoto
 
Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006Alex Kiselyov
 
Enzyme Labs Poster annotated
Enzyme Labs Poster annotatedEnzyme Labs Poster annotated
Enzyme Labs Poster annotated
ABDULLAHELSAADAWY
 
Mutated Atox 1 and its interactions with the anticancer drug Cisplatin
Mutated Atox 1 and its interactions with the anticancer drug CisplatinMutated Atox 1 and its interactions with the anticancer drug Cisplatin
Mutated Atox 1 and its interactions with the anticancer drug Cisplatin
Gaurav Dwivedi
 
CHM462 Poster Presentation By Alexander Ward (1)
CHM462 Poster Presentation By Alexander Ward (1)CHM462 Poster Presentation By Alexander Ward (1)
CHM462 Poster Presentation By Alexander Ward (1)Alexander Ward
 
Science-2007-Kolodkin-Gal-652-5
Science-2007-Kolodkin-Gal-652-5Science-2007-Kolodkin-Gal-652-5
Science-2007-Kolodkin-Gal-652-5Ilana Kolodkin
 
Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...
Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...
Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...
Journal of Agriculture and Crops
 
Atp as a biological hydrotrope
Atp as a biological hydrotropeAtp as a biological hydrotrope
Atp as a biological hydrotrope
victorcdk
 
Raja Sivanantham Ulster Uni Coleraine B Sc Research Slides
Raja Sivanantham Ulster Uni Coleraine B Sc Research SlidesRaja Sivanantham Ulster Uni Coleraine B Sc Research Slides
Raja Sivanantham Ulster Uni Coleraine B Sc Research SlidesRaja Sivanantham
 
SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...
SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...
SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...
Simona Cavalu
 
Voss et al. - 2006 - Identification and characterization of riproximin,
Voss et al. - 2006 - Identification and characterization of riproximin,Voss et al. - 2006 - Identification and characterization of riproximin,
Voss et al. - 2006 - Identification and characterization of riproximin,Cristina Voss
 
Psp1 enzymes and metabolism poster
Psp1 enzymes and metabolism posterPsp1 enzymes and metabolism poster
Psp1 enzymes and metabolism poster
RebeccaLindley5
 

What's hot (19)

WBC 2016 Poster
WBC 2016 PosterWBC 2016 Poster
WBC 2016 Poster
 
JB REU Report
JB REU ReportJB REU Report
JB REU Report
 
Effects of eugenol on resting tension of rat atria
Effects of eugenol on resting tension of rat atriaEffects of eugenol on resting tension of rat atria
Effects of eugenol on resting tension of rat atria
 
Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006Nat_Chem_Biol_GPR30_2006
Nat_Chem_Biol_GPR30_2006
 
Publication
PublicationPublication
Publication
 
Enzyme Labs Poster annotated
Enzyme Labs Poster annotatedEnzyme Labs Poster annotated
Enzyme Labs Poster annotated
 
c4ra02698e
c4ra02698ec4ra02698e
c4ra02698e
 
Mutated Atox 1 and its interactions with the anticancer drug Cisplatin
Mutated Atox 1 and its interactions with the anticancer drug CisplatinMutated Atox 1 and its interactions with the anticancer drug Cisplatin
Mutated Atox 1 and its interactions with the anticancer drug Cisplatin
 
CHM462 Poster Presentation By Alexander Ward (1)
CHM462 Poster Presentation By Alexander Ward (1)CHM462 Poster Presentation By Alexander Ward (1)
CHM462 Poster Presentation By Alexander Ward (1)
 
Science-2007-Kolodkin-Gal-652-5
Science-2007-Kolodkin-Gal-652-5Science-2007-Kolodkin-Gal-652-5
Science-2007-Kolodkin-Gal-652-5
 
ResearchReport
ResearchReportResearchReport
ResearchReport
 
Crowding
CrowdingCrowding
Crowding
 
Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...
Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...
Some Kinetic Properties and Inhibition of Glutathione S-Transferase from a Hy...
 
Atp as a biological hydrotrope
Atp as a biological hydrotropeAtp as a biological hydrotrope
Atp as a biological hydrotrope
 
Raja Sivanantham Ulster Uni Coleraine B Sc Research Slides
Raja Sivanantham Ulster Uni Coleraine B Sc Research SlidesRaja Sivanantham Ulster Uni Coleraine B Sc Research Slides
Raja Sivanantham Ulster Uni Coleraine B Sc Research Slides
 
SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...
SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...
SIMONA CAVALU_EPR study of non covalent spin labeled serum albumin and haemog...
 
Nath et al
Nath et alNath et al
Nath et al
 
Voss et al. - 2006 - Identification and characterization of riproximin,
Voss et al. - 2006 - Identification and characterization of riproximin,Voss et al. - 2006 - Identification and characterization of riproximin,
Voss et al. - 2006 - Identification and characterization of riproximin,
 
Psp1 enzymes and metabolism poster
Psp1 enzymes and metabolism posterPsp1 enzymes and metabolism poster
Psp1 enzymes and metabolism poster
 

Viewers also liked

Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016
younus johan
 
Pain
Pain Pain
Cholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical applicationCholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical applicationDr.UMER SUFYAN M
 
ORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEWORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEWSrirama Anjaneyulu
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
Nandinii Ramasenderan
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
Fatma Faris
 
Organophosphorous poisoning
Organophosphorous poisoningOrganophosphorous poisoning
Organophosphorous poisoningfrooty21
 
Mysthenia Gravis.ppt
Mysthenia Gravis.pptMysthenia Gravis.ppt
Mysthenia Gravis.pptShama
 
Pharmacology cholinergic agonist
Pharmacology   cholinergic agonistPharmacology   cholinergic agonist
Pharmacology cholinergic agonistMBBS IMS MSU
 
ORGANOPHOSPHATE POISONING AND MANAGEMENT
ORGANOPHOSPHATE POISONING AND MANAGEMENTORGANOPHOSPHATE POISONING AND MANAGEMENT
ORGANOPHOSPHATE POISONING AND MANAGEMENT
Mohamed Fowzan
 
Cholinergic antagonists medicinal chemistry
Cholinergic antagonists medicinal chemistryCholinergic antagonists medicinal chemistry
Cholinergic antagonists medicinal chemistry
kaami16
 

Viewers also liked (16)

Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016Cholinergic pharmacology younus h johan 2016
Cholinergic pharmacology younus h johan 2016
 
Pain
Pain Pain
Pain
 
Cholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical applicationCholinergic receptors,funtion and its clinical application
Cholinergic receptors,funtion and its clinical application
 
ORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEWORGANOPHOSPHOROUS POISONING NEUROVIEW
ORGANOPHOSPHOROUS POISONING NEUROVIEW
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Organophosphate poisoning
Organophosphate poisoningOrganophosphate poisoning
Organophosphate poisoning
 
Organophosphorous poisoning
Organophosphorous poisoningOrganophosphorous poisoning
Organophosphorous poisoning
 
Op Poisoning
Op PoisoningOp Poisoning
Op Poisoning
 
Mysthenia Gravis.ppt
Mysthenia Gravis.pptMysthenia Gravis.ppt
Mysthenia Gravis.ppt
 
Myasthenia Gravis - Pathophysiology, Cl. Features, DD
Myasthenia Gravis - Pathophysiology, Cl. Features, DDMyasthenia Gravis - Pathophysiology, Cl. Features, DD
Myasthenia Gravis - Pathophysiology, Cl. Features, DD
 
Pharmacology cholinergic agonist
Pharmacology   cholinergic agonistPharmacology   cholinergic agonist
Pharmacology cholinergic agonist
 
ORGANOPHOSPHATE POISONING AND MANAGEMENT
ORGANOPHOSPHATE POISONING AND MANAGEMENTORGANOPHOSPHATE POISONING AND MANAGEMENT
ORGANOPHOSPHATE POISONING AND MANAGEMENT
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 
Cholinergic antagonists medicinal chemistry
Cholinergic antagonists medicinal chemistryCholinergic antagonists medicinal chemistry
Cholinergic antagonists medicinal chemistry
 

Similar to Cholinesterase Paper

Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Ailen Ramos
 
0165-1218%2884%2990081-8.pdf
0165-1218%2884%2990081-8.pdf0165-1218%2884%2990081-8.pdf
0165-1218%2884%2990081-8.pdf
ergrthdfhdh
 
Eckenhoff et al 2001
Eckenhoff et al 2001Eckenhoff et al 2001
Eckenhoff et al 2001Kin Chan
 
Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...
Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...
Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...
Mohd Aijaz
 
Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...
Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...
Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...
iosrjce
 
Characterization of the human HCN1 channel and its inhibition by capsazepine
Characterization of the human HCN1 channel and its inhibition by capsazepineCharacterization of the human HCN1 channel and its inhibition by capsazepine
Characterization of the human HCN1 channel and its inhibition by capsazepineShahnaz Yusaf
 
Histamine.ppt
Histamine.pptHistamine.ppt
Histamine.ppt
IsabellaThomas8
 
Isolation of enzyme and their assay
Isolation of enzyme and their assay Isolation of enzyme and their assay
Isolation of enzyme and their assay
GOPAL KHODVE
 
articulo
articulo articulo
articulo
Monserrath96
 
My Researches
My ResearchesMy Researches
My Researches
Manimegala
 
2014_BKCS_기생충
2014_BKCS_기생충2014_BKCS_기생충
2014_BKCS_기생충Je-Hyun Baek
 
SIMONA CAVALU_BIOPOLYMERS
SIMONA CAVALU_BIOPOLYMERSSIMONA CAVALU_BIOPOLYMERS
SIMONA CAVALU_BIOPOLYMERSSimona Cavalu
 
housman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percenthousman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percentJonathan Oyler
 
Determination of DNA Methylation Using Electrochemiluminescenc.docx
Determination of DNA Methylation Using Electrochemiluminescenc.docxDetermination of DNA Methylation Using Electrochemiluminescenc.docx
Determination of DNA Methylation Using Electrochemiluminescenc.docx
khenry4
 
Synthesis, spectral characterization and bioactivity studies of some S-substi...
Synthesis, spectral characterization and bioactivity studies of some S-substi...Synthesis, spectral characterization and bioactivity studies of some S-substi...
Synthesis, spectral characterization and bioactivity studies of some S-substi...
Jing Zang
 

Similar to Cholinesterase Paper (20)

Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
 
0165-1218%2884%2990081-8.pdf
0165-1218%2884%2990081-8.pdf0165-1218%2884%2990081-8.pdf
0165-1218%2884%2990081-8.pdf
 
Eckenhoff et al 2001
Eckenhoff et al 2001Eckenhoff et al 2001
Eckenhoff et al 2001
 
Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...
Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...
Cardio-protective and antioxidant properties of caffeic acid and chlorogenic ...
 
Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...
Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...
Effect of estradiol -17 β on arachidonic acid metabolism in sheep uterus: in ...
 
Characterization of the human HCN1 channel and its inhibition by capsazepine
Characterization of the human HCN1 channel and its inhibition by capsazepineCharacterization of the human HCN1 channel and its inhibition by capsazepine
Characterization of the human HCN1 channel and its inhibition by capsazepine
 
Eur J Physiol 436 1998
Eur J Physiol 436 1998Eur J Physiol 436 1998
Eur J Physiol 436 1998
 
PDF Article Filtration
PDF Article FiltrationPDF Article Filtration
PDF Article Filtration
 
Whyte_2013
Whyte_2013Whyte_2013
Whyte_2013
 
Histamine.ppt
Histamine.pptHistamine.ppt
Histamine.ppt
 
Isolation of enzyme and their assay
Isolation of enzyme and their assay Isolation of enzyme and their assay
Isolation of enzyme and their assay
 
articulo
articulo articulo
articulo
 
My Researches
My ResearchesMy Researches
My Researches
 
2014_BKCS_기생충
2014_BKCS_기생충2014_BKCS_기생충
2014_BKCS_기생충
 
SIMONA CAVALU_BIOPOLYMERS
SIMONA CAVALU_BIOPOLYMERSSIMONA CAVALU_BIOPOLYMERS
SIMONA CAVALU_BIOPOLYMERS
 
housman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percenthousman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percent
 
2003 relaxation of uterine and aortic smooth muscle by glaucolides
2003 relaxation of uterine and aortic smooth muscle by glaucolides2003 relaxation of uterine and aortic smooth muscle by glaucolides
2003 relaxation of uterine and aortic smooth muscle by glaucolides
 
Biotech lett
Biotech lettBiotech lett
Biotech lett
 
Determination of DNA Methylation Using Electrochemiluminescenc.docx
Determination of DNA Methylation Using Electrochemiluminescenc.docxDetermination of DNA Methylation Using Electrochemiluminescenc.docx
Determination of DNA Methylation Using Electrochemiluminescenc.docx
 
Synthesis, spectral characterization and bioactivity studies of some S-substi...
Synthesis, spectral characterization and bioactivity studies of some S-substi...Synthesis, spectral characterization and bioactivity studies of some S-substi...
Synthesis, spectral characterization and bioactivity studies of some S-substi...
 

Cholinesterase Paper

  • 1. CHARACTERIZATIONS OF HORSE SERUM CHOLINESTERASE FOR MOLECULAR WEIGHT AND ANALYSIS UNDER ENVIRONMENTAL CONDITIONS Lukas Isenhart, Sage Jordan, Leo Pezzementi Biology Department Birmingham-Southern College Birmingham, Alabama 2 May, 2014
  • 2. 2 Abstract: After analysis of horse blood serum cholinesterase for substrate specificity, kinetic parameters, substrate inhibition, molecular weight, and effects of temperature, pH, and [NaCl], we determined the enzyme inherent in horse serum to be butyrylcholinesterase (BChE). The enzyme experienced inhibition by substrates too large to bind to an actyl gorge of acetylcholinesterase (AChE) and displayed responses to pH, temperature, and [NaCl] – these results confirm the data of previous studies that also suggested the existence of BChE in horse serum. 1. Introduction Acetylcholine, a neurotransmitter in humans and many other organisms, functions as an excitatory signal for the contraction of skeletal muscle fibers. If not for cholinesterases (ChEs) – which are a family of enzymes known to catalyze the hydrolysis of acetylcholine into choline and acetic acid, thereby impeding the neurotransmitter’s ability to signal contraction – skeletal muscles would be incapable of relaxation (Pohanka, 2011). Despite their differences in substrate specificity and susceptibility to inhibitors, butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) both qualify as cholinesterases (Radic and Taylor, 2006; Monteiro et al., 2005). AChE is easily observed in the central nervous system and in neuromuscular junctions, functioning as the primary enzyme involved in the hydrolysis of acetylcholine, but BChE isn’t understood so well. Though more commonly found in the liver and serum of organisms (Radic and Taylor, 2006), people completely deficient in BChE can lead generally healthy, disease-free lives (Manoharan et al., 2007). BChE is known to improve the hydrolysis rates of cocaine (Lynch et al., 1997), protect mice from cocaine’s toxic effects (Morasco and Goldfrank, 1996), and protect the human body from organophosphorous AChE inhibitors, suggesting a detoxification role in the body (Saxena et al., 2006). AChE is structurally determined to have much narrower substrate specificity than BChE, as they bind specifically to ACh. BChE has a wider active site than Torpedo californica AChE,
  • 3. 3 with the AChE having a catalytic gorge – lined mostly with aromatic residues – that reaches halfway into the protein (Sussman et al., 1991). The existence of large aromatic residues from the volume of the AChE aromatic gorge creates a long and narrow path for substrates, allowing for higher selectivity of the enzyme at its active site (Sussman et al., 1991). Substrates that bind to the choline binding site at the base of the AChE are smaller and more positively charged due to the charge of the many different negatively-charged aromatic residues. The enzyme would require more positively charged substrates or inhibitors than BChE. BChE’s active site is wider, it has fewer aromatic residues lining the catalytic gorge and therefore is more voluminous and more easily accommodating for various substrates, specifically for butyrylcholine (Nicolet et al., 2003). This difference in substrate specificities can prove to be a valuable tool in the identification of enzymes within sera. The larger and wider size of BChE’s catalytic gorge also allows for easier binding of inhibitors that may bind in the gorge and at an active site by the acyl pocket, there isn’t any substrate inhibition at peripheral site due to BChE’s possession of an alanine instead of a tryptophan. Vertebrate sera each display different levels of certain cholinesterases. The dominant cholinesterase present in plasma of Portugese bird species Morus bassanus, Ciconia ciconia, and Ardea cinerea is BChE (Santos et al., 2012). The plasma of other bird species, including Neophron percnopterus, Cincloramphus cruralis, Anthus novaeseelandiae, and Accipiter nisus, also displayed a dominance of BChE (Strum et al., 2008; Fildes et al., 2009). BChE, as it appears in human blood serum, has an estimated molecular weight of 366,000 after ultracentrifugation and gel electrophoresis (Dasan and Liddell, 1969). It is reported that BChE also appears in horse serum and can be commercially purified, resulting in a molecular weight of 317,000 ± 12,000 in a diluted phosphate (Lee and Harpst, 1971).
  • 4. 4 With regard to inhibition of cholinesterases, human AChE displays more inhibition resulting from pyrilium and selenopyrilium salts than does horse BChE while horse BChe is more easily inhibited by thiopyrilium salts than human AChE, suggesting a method for identification of the type of enzyme in horse serum by analyzing response to salts (Brestkin et al., 1988). In rat brain capillaries, BChE displayed longer functionality at higher temperatures and a higher activation energy at normal body temperatures than did AChE (Hernandez and Catalan, 1986). Additionally, cholinesterase enzyme activity increased at pH values ranging from 5 to 10 before denaturing at pH of 11 (Eränkö, 1972). Based on the dominant appearance of BChE in horse serum as suggested by Lee and Harpst (1971), we hypothesize that BChE will again be the dominant cholinesterase in horse serum after filtration and analysis for molecular weight. This study will determine the type of cholinesterase inherent in horse serum as well as address its molecular characteristics and interactions with substrates and environment factors. 2. Materials and Methods 2.1. Preparation for and Execution of Electrophoresis A sample containing purified cholinesterase was added directly to sample buffer (0.5 M Tris- HCL, pH 6.8, 10% glycerol, 0.2% SDS, 0.25%bromophenol blue) at the same volume. This solution and a solution containing molecular weight standards (proteins with standard weights of 250, 150, 100, 75, 50, 37, 25, 20, 15, and 10 kD) were heated for 4 minutes at 95ºC. Samples of 15µg for molecular weight standards and 7.5 and 12.5µg of purified cholinesterase (mixed with sample buffer) were loaded into an electrophoresis chamber above 4-20% polyacrylamide gel. The samples were electrophoresed in running buffer (0.25 M Tris, 0.2M glycine and 0.1% SDS) at 200 V for 30 minutes.
  • 5. 5 2.2. Staining SDS-polyacrylamide Gel After electrophoresis the gel was removed from the gel cassette, incubated in dH2O for 5 minutes, then gently shaken for 1 hour in Bio-Safe Coomassie staining solution. The gel was then incubated in dH2O overnight. 2.3. Measurement of Sample Migrations The gel was removed from the dH2O and placed on a light box. Measurements of migration distances were recorded in mm from the base of each well to the leading edge of each band in all molecular weight and cholinesterase samples. 2.4. Plotting Data Using Sigma Plot, log values of standard molecular weights were plotted in relation to distance (mm). To determine the molecular weight of horse serum cholinesterase the equation Y=M(X)+B was used and Y was solved for using values of slope, distance migrated, and y- intercept. We then determined the anti-log of Y to find the molecular weight of horse serum cholinesterase. 2.5. Effects of Environmental Temperature Enzyme samples and blanks containing identical pH values and [NaCl] concentrations were heated for ten minutes at individual temperatures ranging between 4º and 90ºC, where 4ºC acted as the control temperature and other higher temperatures were experimental values. After heating, each sample was chilled in an ice bath to preserve the enzyme’s resulting shape. Spectrophotometric analyses were staggered in five minute intervals; each analysis involved spectrophotometry for 2 minutes while allowing time for other preparatory processes. After each 2 minute sample-analysis at ice bath temperature, a sample’s resulting slope was converted into
  • 6. 6 percent control activity. Staggered time intervals continued until every blank and sample experienced analysis by the spectrophotometer. Data were then plotted using Sigma Plot. 2.6. Effects of Environmental pH Enzyme samples existed in Ellman’s solutions with a pH range of 4.5-8.5,where the pH value of 7 acted as a control. The spectrophotometer was blanked before each measurement, where an experimental pH value would receive an enzyme and incubate at room temperature for approximately 10 minutes before receiving a dose of substrate with buffer before spectrophotometric analysis for two minutes. Experimental analyses were staggered every 5 minutes, resulting slopes were converted to percent control activity, then the converted data was organized using Sigma Plot software. Complacency 2.7. Effects of Environmental [NaCl] This procedure is similar to the analysis of pH’s effects on enzyme activity. Aside from replacing pH addition with the addition of [NaCl] molarities ranging from 0 to 2.5 M, where 0M acted as a control, the procedure for spectrophotometric analysis of [NaCl] and its effects on horse serum cholinesterase is virtually identical to that of environmental pH.
  • 7. 7 3. Results Figure 1. Substrate specificities of horse serum cholinesterases. Data inidicate initial velocities of ATCh’s and BTCh’s after Ellman esterase assay of serial dilutions. Acetylthiocholine specificities represented by (●), butyrlthiocholine represented by (○). Horse serum cholinesterases exhibited higher velocities of cholinesterase activity at higher substrate concentrations. BTCh exhibited more substrate activity than ATCh, but activity level out at approximately 1.0mM (Fig. 1.). Table 1. Kinetic parameters for hydrolysis of ATCh and BTCh by horse serum cholinesterase. Substrate concentration (Km) calculated at 0.5 maximum velocity; maximum velocity (Vmax) was also calculated. Standard error suggests N=14. Substrate Km (mM ± SE) Vmax (µm/mM ± SE) ATCh 0.34 ± 0.08 43.29 ± 4.24 BTCh 0.28 ± 0.06 59.16 ± 3.20 Lower concentrations of BTCh still managed to produce higher maximum velocities during hydrolysis than did ATCh, though SE values do suggest overlapping standard errors for concentrations (Table 1.). Maximum velocity values differed even when including standard error values, suggesting that BTCh has a higher maximum velocity than ATCh (Table 1.).
  • 8. 8 Inhibitor Concentration (M) 10-11 10-10 10-9 10-8 10-7 10-6 10-5 10-4 10-3 10-2 PercentControlChE 0 20 40 60 80 100 120 140 Figure 2. Percent activity of horse serum cholinesterase as a function of inhibitor concentrations. This depicts data resulting from the addition of inhibitors Iso-OMPA (○), BW284C51 (▼), and Eserine (●) into Ellman esterase assay. The results analyzed as percent activity in regard to inhibitor concentration (M). N=4 for Eserine and BW284C51while N=5 for Iso-OMPA. Ic50 values for inhibitors include 1.7294E-007 (Eserine), 2.5548E-006 (Iso-OMPA), and 3.8881E-005 (BW284c51) (Fig. 2.). As inhibitor concentrations increased, percent control ChE decreased; Eserine percent control ChE decreased sooner than other inhibitors while BW284C51 decreased at slowest rate (Fig. 2.).
  • 9. 9 Table 2. Inhibitor dimensions of molecular modeling by SPARTAN software. Inhibitor Length ± SE Width ± SE BW284c51 20.92 ± 0.53 5.24 ± 0.29 Decamethonium 18.37 ± 0.33 3.94 ± 0.28 Ethopropazine 9.69 ± 0.28 8.72 ± 0.35 Iso-OMPA 9.58 ± 0.35 8.09 ± 0.53 Decamthionium and BW284c51 exhibited molecular shapes that were longer and thinner than the molecular shapes of Ethopropazine and Iso-OMPA, which were shorter and wider (Table 2.). Distance Migrated (mm) 10 20 30 40 50 60 70 MolecuarWeight 103 104 105 106 Figure 3. Distance migrated (mm) after electrophoresis for 30 minutes at 200V by samples (µg) of molecular weight standards and purified cholinesterase. Lane 1 of electrophoresis gel represents molecular weight standard to specified masses (kD), lane 2 contains 12.5µg purified cholinesterase while Lane 3 contains 7.5µg purified cholinesterase. Standard molecular weights displayed an inverse relationship with distance migrated – larger molecular weights (the bands in the gel) travelled shorter distances than smaller molecular weights (Fig. 1). The molecular weight of horse serum cholinesterase was determined to be 66456 + 2839; N=10 (Fig. 1.). Lanes 1 2 3 10kD 15kD 20kD 25kD 37kD 50kD 75kD 100kD 150kD 250kD
  • 10. 10
  • 11. 11 Figure 4. Varying Effects of Environmental Factors on Horse Serum Cholinesterase. Graph A displays effects of pH in a sigmoidal fashion, where percent control activity increased until an approximate pH value of 8; data normalized to pH of 7. Graph B displays effects of Temperature as measured in degrees Celsius, lacking dramatic changes resulting from temperature until a 50°C where the enzyme percent activity declines and flatlines at 0; data normalized to 100°C Graph C displays the negative correlation between increasing molarity of [NaCl] and percent control ChE activity; data normalized to 0 M. Data are the mean of standard error and 9 determinations. Horse Serum Cholinesterase activity experienced positive responses to less acidic environments, with pH values displaying a sigmoidal relationship (Fig. 1.). Activity as a function of pH, lower values led to less control cholinesterase activity whereas higher function of pH values led to the higher percent control cholinesterase activity (Fig. 1A). Standard SE values overlap between data points 8 and 9, suggesting the insignificance of apparent reduction in percent control cholinesterase activity (Fig. 1.). Cholinesterase activity in horse serum also experienced a sharp decline in functional ability after relatively constant responses to environmental temperature, but when temperature values rose above 40°C percent control cholinesterase activity dipped and flat-lined at 0% around 70°C (Fig. 1.). Horse serum
  • 12. 12 cholinesterases additionally experienced a negative relationship with rising molarities of [NaCl], with the highest molarity of 2.5 displaying the least percent control cholinesterase activity (Fig. 1.). 4. Discussion Horse serum cholinesterases displayed a highly-accomodating substrate specificity for larger, wider substrates like Ethopropazine and Iso-OMPA, suggesting that the enzyme in horse serum possessed an adequately-sized catalytic gorge to allow the entrance of such inhibitors (Fig. 2.). Enzyme activity increased as butyrylthiocholine concentrations increased, also suggesting that the enzyme had increased binding capabilities with substrates of varying lengths and widths, a common characteristic of BTChE and an idea common with previous research (Sussman et al., 1991) (Fig. 1.). Molecular modeling represents BW284c51and Decamethonium as inhibitors exhibiting substrate specifity for long and thin catalytic gorges of enzymes while Ethopropazineand and Iso-OMPA exhibit larger and wider enzyme specificities (Table 2.). It appears that BChE is the dominant enzyme available in horse serum because the enzyme is accepting of both ACh and BCh while also displaying more inhibition to varying sizes and shapes of inhibitors. The existence of 14 large aromatic residues in the aromatic gorge of AChE explains its high specificity, as the aromatic residues fill the gorge and leave little remaining space for the entrance of substrates (Sussman et al., 1991). Because of this narrower gorge in AChE , it would be expected that BCh – a larger, wider molecule – would produce slower kinetic interactions with that particular enzyme because the substrate simply wouldn’t fit inside the catalytic gorge (Table 2). But within this experiment the enzyme displayed an increased kinetic relationship with BCh and ACh, which again suggests the existence of BChE as the enzyme inherent in horse
  • 13. 13 serum due to its more accommodating substrate specificity resulting from ist possession of only 8 aromatic amino acids (Table. 1.). This accomodation also helps explain BChE’s effectiveness as a detoxifying agent in mice and humans (Morasco and Goldfrank, 1996; Saxena et al., 2006; Lynch et al., 1997). Environmental factors affected horse serum cholinesterase in various manners, with enzymes functioning best at a pH of 8, a temperature of 0 to 40°C, and at low (0 – 0.5M) concentrations of [NaCl] (Fig. 4.). These data indicate optimum conditions for the horse serum cholinesterase, further identify the enzyme to be BChE (Brestkin et al., 1988; Hernandez and Catalan, 1986; Eränkö, 1972). Though data for molecular weight differed from previous literature – likely a result oft he differences between monomer and tetramer analyses – data in this study pertaining to environmental factors, substrate specificities, and enzyme kinetics correspond with a previous studies’ assertions that the enzyme inherent in horse serum is BChE (Lee and Harpst, 1971; Sussman et al., 1991). The molecular weight of horse serum cholinesterase in this experiment was deterimined to be (66456 + 2839; N=10) (Fig. 1.). However, there are multiple issues with this study. All treatments to determine environmenatal variability and protein function required staggered measurement periods by spectrophotometry, inconsistent machine-blanking and transfer times between the addition of substrates and actual measurement of cuvettes in the spectrophotomer likely led to discrepencies in data. Data measurements were rushed, future studies should eliminate the propensity for measurement mistakes by individually analyzing test solutions. 5. Acknowledgements We would like to thank Birmingham-Southern College both for generously supplying materials and for allowing the use of facilities.
  • 14. 14 Literature Cited Brestkin, A.P., E.N. Dmitrieva, I.G. Zhukovskiĭ, A.A. Safonova and V.A. Sedavkina (1988) Reversible inhibition of cholinesterases by salts of pyrilium, thiopyrilium and selenopyrilium derivatives. Ukr. Biokhim. Zh. 60, 35-40. Dasan, P.K. and J.D. Liddell (1969) Purification and Properties of Human Serum Cholinesterase. Biochem. J. 116, 875-881. Eränkö, L. (1972) Effect of pH on the activity of nervous cholinesterases of the rat towards different biochemical and histochemical substrates and inhibitors. Histochemie 33, 1-14. Fildes, K., J.K. Szabo, M.J. Hooper, W.A. Buttemer and L.B. Astheimer (2009) Plasma cholinesterase characteristics in native Australian birds: significance for monitoring avian species for pesticide exposure. EMU 109, 41–47. Hernandez, F. and R.E. Catalan (1986) Temperature effects on cholinesterases from rat brain capillaries. Biosci. Rep. 6, 573-577. Lee, J.C. and J.A. Harpst (1971) Purification and properties of butyrylcholinesterase from horse serum. Arch. Biochem. Biophys.145, 55-63. Lynch, T.J., C.E. Mattes, A. Singh, R.M. Bradley, R.O. Brady and K.L. Dretchen (1997) Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol. Appl. Pharmacol. 145, 363–371. Manoharan, I., R. Boopathy, S. Darvesh and O. Lockridge (2007) A medial health report on individuals with silent butyrylcholinesterase in Vysya community of India. Clin. Chim. Acta. 378, 128-35. Monteiro, M., C. Quintaneiro, F. Morgado, A. Soares and L. Guilhermino (2005) Characterization of the cholinesterases present in head tissues of the estuarine fish Pomatoschistus microps: Application to biomonitoring. Ecotoxicol. Environ. Saf. 62, 341–347. Morasco, R.S. and L.R. Goldfrank (1996) Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. J. Toxicol. Clin. Toxicol. 34, 259–266. Nicolet, Y., O. Lockridge, P. Masson, J.C. Fontecilla-Camps and F. Nachon (2003) Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J. Biol. Chem. 278, 41141-41147. Pohanka, M. (2011) Cholinesterases, a target of pharmacology and toxicology. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 155, 219-229.
  • 15. 15 Radic, Z. and P. Taylor (2006) Toxicology of Organophosphate and Carbamate Pesticides. Elsevier Academic Press. 1, 161–186. Santos, C., M.S. Monteiro, A.M. Soares and S. Loureiro (2012) Characterization of Cholinesterases in Plasma of Three Portuguese Native Bird Species: Application to Biomonitoring. PLoS ONE 7, 1-8. Saxena, A., W. Sun, C. Luo, T.M. Myers, I. Koplovitz, D.E. Lenz, and B.P. Doctor (2006) Bioscavenger for protection from toxicity of organophosphorus compounds. J. Mol. Neurosci. 30, 145-148. Strum, K.M., M. Alfaro, B. Haase, M.J. Hooper, K.A. Johnson, R.B. Lanctot, A.J. Lesterhuis, L. López, A.C. Matz, C. Morales, B. Paulson, B.K. Sandercock, J. Torres-Dowdall and M.E. Zaccagnini (2008) Plasma cholinesterases for monitoring pesticide exposure in nearctic- neotropical migratory shorebirds. Ornitologia Neotropical 19, 641-651. Sussman, J. L., M. Harel, F. Frolow, C. Oefner, A. Goldman, L. Toker and I. Silman (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253, 872–879.